Pages that link to "Q36243815"
Jump to navigation
Jump to search
The following pages link to FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII. (Q36243815):
Displaying 39 items.
- CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond (Q39246685) (← links)
- Complexity of immune responses to AAV transgene products - Example of factor IX. (Q39394803) (← links)
- Hemophilia A inhibitor treatment: the promise of engineered T-cell therapy (Q39398719) (← links)
- Antigen-specific regulatory T cells: are police CARs the answer? (Q39422353) (← links)
- Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision (Q42072531) (← links)
- Engineering Specificity and Function of Therapeutic Regulatory T Cells. (Q45875046) (← links)
- From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance (Q45875104) (← links)
- Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A. (Q45875675) (← links)
- T cells expressing chimeric antigen receptor promote immune tolerance. (Q46045077) (← links)
- Therapeutic application of T regulatory cells in composite tissue allotransplantation. (Q46772183) (← links)
- Engineered Tolerance: Tailoring Development, Function, and Antigen-Specificity of Regulatory T Cells (Q47150746) (← links)
- Posttransplant chimeric antigen receptor therapy (Q47550219) (← links)
- Regulatory T Cells: Molecular and Cellular Basis for Immunoregulation (Q48668293) (← links)
- Current Status of Gene Engineering Cell Therapeutics (Q49829282) (← links)
- CD137 CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures. (Q50281162) (← links)
- Engineering therapeutic T cells to suppress alloimmune responses using TCRs, CARs, or BARs (Q52336320) (← links)
- Gene Therapy With Regulatory T Cells: A Beneficial Alliance. (Q52721830) (← links)
- Engineered FVIII-expressing cytotoxic T cells target and kill FVIII-specific B cells in vitro and in vivo (Q57150012) (← links)
- Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance (Q58122555) (← links)
- Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes (Q58726929) (← links)
- Non-replacement therapy for haemophilia treatment: fetching the east by the west (Q58776114) (← links)
- Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells (Q64066337) (← links)
- Chimeric antigen receptor costimulation domains modulate human regulatory T cell function. (Q64974096) (← links)
- Gene editing for immune cell therapies (Q67201058) (← links)
- Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses (Q88506528) (← links)
- Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells (Q88953756) (← links)
- Promises and limitations of immune cell-based therapies in neurological disorders (Q89170899) (← links)
- Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies (Q89495089) (← links)
- Next-generation regulatory T cell therapy (Q90197782) (← links)
- Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells (Q90320536) (← links)
- New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes (Q90334692) (← links)
- CAR T cells for infection, autoimmunity and allotransplantation (Q90475786) (← links)
- TGF-β-responsive CAR-T cells promote anti-tumor immune function (Q90677434) (← links)
- Antigen-specific in vitro expansion of factor VIII-specific regulatory T cells induces tolerance in hemophilia A mice (Q90687084) (← links)
- Escape or Fight: Inhibitors in Hemophilia A (Q91711964) (← links)
- Treg cell-based therapies: challenges and perspectives (Q91768573) (← links)
- Genetic Engineering of T Cells for Immune Tolerance (Q92622092) (← links)
- Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy (Q93024302) (← links)
- Tolerating Factor VIII: Recent Progress (Q93052070) (← links)